文献速递运动医学关节外科

新鲜冷冻同种异体半月板移植采用桥槽技术的最小10年临床结局与移植物存活率

Minimum 10-Year Clinical Outcomes and Survivorship of Meniscal Allograft Transplantation With Fresh-Frozen Allografts Using the Bridge-in-Slot Technique.
PubMed 文献 · Am J Sports Med · 2023-08-18

该回顾性病例系列纳入2001至2012年接受初次新鲜冷冻同种异体半月板移植(桥槽技术)的174例患者,平均随访12.7年。所有患者报告结局评分在各时间点均较术前显著改善(P≤.0001),10年无再次手术和失败存活率分别为73%和85%,15年分别为60%和72%,86%患者对术后整体状况满意。

要点

  • 初次半月板移植采用新鲜冷冻移植物和桥槽技术,最小10年随访显示患者报告结局显著改善。
  • 10年无半月板再次手术存活率73%、无失败存活率85%;15年分别为60%和72%。
  • 37%患者发生再次手术,23%符合失败标准,7%行翻修移植,15%转为关节置换。

核心结论

  • 初次半月板移植在最小10年随访中显示出有效性和持久性,患者满意度高。
  • 应告知患者15年时再次手术率可能接近40%,但翻修移植和转为关节置换的总体长期比率仍较低。

研究设计与样本

  • 病例系列研究,证据等级4级。
  • 回顾性分析前瞻性收集的数据,纳入2001至2012年间接受初次半月板移植的患者。
  • 共174例患者符合纳入标准,平均随访12.7±2.7年(范围10.0-21.0年)。

主要发现

  • 所有患者报告结局指标(Lysholm、国际膝关节文献委员会主观评分、膝关节损伤和骨关节炎结局评分亚量表)在各时间点均较术前显著改善(P≤.0001)。
  • 37%患者(65例)在术后平均6.6±5.5年(范围0.3-16.7年)接受半月板再次手术。
  • 23%患者(40例)在术后平均7.3±5.0年(范围1.0-17.4年)符合失败标准,其中22例曾接受半月板再次手术。
  • 末次随访时,7%患者(13例)行翻修半月板移植,15%患者(27例)转为关节置换。
  • 无半月板再次手术和失败的移植存活率:10年分别为73%和85%,15年分别为60%和72%。

关键数值与推荐

  • 失败定义为翻修半月板移植或转为关节置换。
  • 再次手术定义为对移植半月板的后续手术干预,包括部分或全部半月板切除、半月板修复或上述定义的失败。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Meniscal allograft transplantation (MAT) has been shown to provide clinical benefits in patients with symptomatic meniscal deficiency in the short term and midterm. There is, however, a paucity of data regarding long-term outcomes after MAT using fresh-frozen allografts and the bridge-in-slot technique. PURPOSE: To report clinical outcomes and revision rates after primary MAT with fresh-frozen allografts and the bridge-in-slot technique in a large case series of patients at a 10-year minimum follow-up. STUDY DESIGN: Case series; Level of evidence, 4. METHODS: A retrospective review of prospectively collected data was performed on patients undergoing primary MAT between 2001 and 2012. Lysholm, International Knee Documentation Committee subjective form, and Knee injury and Osteoarthritis Outcome Score subscales were collected preoperatively and at 1-, 2-, 5-, and minimum 10-year follow-ups. Cox proportional hazards modeling was used to identify variables associated with reoperation and failure, defined as revision MAT or conversion to arthroplasty. Reoperation was defined as a subsequent surgical intervention on the transplanted meniscus, including partial or total meniscectomy, meniscal repair, or failure as defined in the previous sentence. RESULTS: A total of 174 patients undergoing MAT met the inclusion criteria and were followed for a mean of 12.7 ± 2.7 years (range, 10.0-21.0 years). The mean age at surgery was 28.3 ± 10.1 years. The patients were predominantly female (n = 92; 53%), and medial MAT was the most commonly performed procedure (n = 91; 52%). Concomitant procedures were performed in 115 patients (66%), with the most common procedure being osteochondral allograft transplantation (n = 59; 34%). Patients demonstrated statistically significant postoperative improvements at all time points for all patient-reported outcome measures (P≤ .0001). A total of 65 patients (37%) underwent a meniscal reoperation at a mean time of 6.6 ± 5.5 years (range, 0.3-16.7 years) postoperatively. A total of 40 patients (23%) met the criteria for failure at a mean time of 7.3 ± 5.0 years (range, 1.0-17.4 years) after MAT, with 22 of these patients having undergone a previous meniscal reoperation. At the final follow-up, 13 patients (7%) had undergone revision MAT and 27 (15%) had converted to arthroplasty. The MAT survival rates free of meniscal reoperation and failure were 73% and 85% at 10 years and 60% and 72% at 15 years, respectively. At the time of the final follow-up, 86% of patients reported that they were satisfied with their overall postoperative condition. CONCLUSION: Primary MAT demonstrates efficacy and durability with high rates of patient satisfaction at a minimum 10-year follow-up. Patients should be counseled that although reoperation rates may approach 40% at 15 years, rates of overall revision MAT and conversion to arthroplasty remain low at long-term follow-up.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Wagner KR, Kaiser JT, Hevesi M, et al. Minimum 10-Year Clinical Outcomes and Survivorship of Meniscal Allograft Transplantation With Fresh-Frozen Allografts Using the Bridge-in-Slot Technique. Am J Sports Med. 2023. PMID: 37594374. doi:10.1177/03635465231188657

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。